ArticleiScience2026

The prognostic utility of a combined PNI-HB immunonutritional index in CD19 CAR T-cell therapy for relapsed/refractory non-Hodgkin lymphoma.

Yifan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.